Advanced search
Publication Cover
OncoImmunology Volume 8, 2019 - Issue 7
Submit an article Journal homepage
837
Views
2
CrossRef citations to date
0
Altmetric
Author’s View

Neo-antigen specific memory T-cell responses in healthy individuals

Morten Orebo HolmströmDepartment of Hematology, Zealand University Hospital, Roskilde, Denmark;National Center for Cancer Immune Therapy, Department of Hematology, Herlev University Hospital, Herlev, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3764-8578View further author information
ORCID Icon,
Hans Carl HasselbalchDepartment of Hematology, Zealand University Hospital, Roskilde, DenmarkORCID Iconhttps://orcid.org/0000-0003-3936-8032View further author information
ORCID Icon &
Mads Hald AndersenNational Center for Cancer Immune Therapy, Department of Hematology, Herlev University Hospital, Herlev, Denmark;Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, DenmarkORCID Iconhttps://orcid.org/0000-0002-2914-9605View further author information
ORCID Icon
Article: e1599640 | Received 11 Mar 2019, Accepted 13 Mar 2019, Published online: 19 Apr 2019

References

  • Spivak JL. Myeloproliferative neoplasms. N Engl J Med. 2017;376(22):2168–2181. doi:10.1056/NEJMra1406186.
  • Ortmann CA, Kent DG, Nangalia J, Silber Y, Wedge DC, Grinfeld J, Baxter EJ, Massie CE, Papaemmanuil E, Menon S, et al. Effect of mutation order on myeloproliferative neoplasms. N Engl J Med. 2015;372(7):601–612. doi:10.1056/NEJMoa1412098.
  • Holmström MO, Riley CH, Svane IM, Hasselbalch HC, Andersen MH. The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms. Leukemia. 2016;30(12):2413–2416. doi:10.1038/leu.2016.233.
  • Holmstrom MO, Martinenaite E, Ahmad SM, Met O, Friese C, Kjaer L, Riley CH, Thor Straten P, Svane IM, Hasselbalch HC, et al. The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy. Leukemia. 2018;32(2):429–437. doi:10.1038/leu.2017.214.
  • Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NCC, Berg T, Gisslinger B, Pietra D, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013;369(25):2379–2390. doi:10.1056/NEJMoa1311347.
  • Holmström MO, Ahmad SM, Klausen U, Bendtsen SK, Martinenaite E, Riley CH, Svane IM, Kjær L, Skov V, Ellervik C, et al. High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals. Blood Cancer J. 2019;9(2):8. doi:10.1038/s41408-018-0166-4.
  • Keilholz U, Letsch A, Busse A, Asemissen AM, Bauer S, Wolfgang I, Hofmann W, Uharek L, Thiel E, Scheibenbogen C, et al. A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS. Blood. 2009;113(26):6541–6548. doi:10.1182/blood-2009-02-202598.
  • Dunn GP, Old LJ, Schreiber RD. The Three Es of Cancer Immunoediting. Annu Rev Immunol. 2004;22(1):329–360. doi:10.1146/annurev.immunol.22.012703.104803.
  • Pittet MJ, Valmori D, Dunbar PR, Speiser DE, Liénard D, Lejeune F, Fleischhauer K, Cerundolo V, Cerottini JC, Romero P. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med. 1999;190(5):705–715. doi:10.1084/jem.190.5.705.
  • Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting : from immuno- surveillance to tumor escape. Nat Immunol. 2002;3(11):991–998. doi:10.1038/ni1102-991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.